Obesity negatively impacts maintenance of antibody response to COVID-19 vaccines
Camille Chauvin, Sruthi Vijaya Retnakumar, Jagadeesh Bayry
Abstract
Severe obesity accelerates the decline of neutralizing antibodies to COVID-19 vaccines contributing to increased risk of hospitalization from breakthrough SARS-CoV-2 infections. 1 These findings have repercussion on the vaccination policy for SARS-CoV-2 variants and other infectious diseases like influenza in obese population.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)VaccinationObesityMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakAntibody responsePopulationAntibodyVirologyImmunologyPandemicEnvironmental healthInfectious disease (medical specialty)Internal medicineOutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesDiabetes and associated disorders